Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 5—May 2009

Dispatch

Reduced Fluoroquinolone Susceptibility in Salmonella enterica Isolates from Travelers, Finland

Marianne M. LindgrenComments to Author , Pirkko Kotilainen, Pentti Huovinen, Saija Hurme, Susanna Lukinmaa, Mark A. Webber, Laura J.V. Piddock, Anja Siitonen, and Antti J. Hakanen
Author affiliations: National Institute of Health and Welfare, Turku, Finland (M.M. Lindgren, P. Kotilainen, P. Huovinen, A.J. Hakanen); Turku University Hospital, Turku (P. Kotilainen, A.J. Hakanen); University of Turku, Turku (S. Hurme); National Institute of Health and Welfare, Helsinki, Finland (S. Lukinmaa, A. Siitonen); University of Birmingham, Birmingham, UK (M.A. Webber, L.J.V. Piddock)

Main Article

Table

Quinolone susceptibility of 499 Salmonella isolates collected from travelers returning to Finland, by country visited, 2003−2007*

Country visited No. (%) isolates No. isolates with CIP MIC >0.125 µg/mL No. isolates with NAL MIC >32 µg/mL No. isolates with NAL MIC <32 µg/mL No. trips from Finland
during study months†
Thailand‡ 212 (42.5) 98 67 31 122,472
Spain§ 66 (13.2) 25 25 0 426,822
Brazil 41 (8.2) 0 0 0 25,009
Egypt 40 (8.0) 17 17 0 47,291
India 32 (6.4) 7 7 0 26,233
Malaysia 15 (3.0) 6 1 5 2,597
Vietnam 9 (1.8) 2 2 0 7,555
Tanzania 9 (1.8) 2 2 0 1,259
Portugal 8 (1.6) 7 7 0 35,899
Morocco 5 (1.0) 3 3 0 8,708
Other areas
62 (12.4)
14
14
0

Total 499 (100) 181 145 36

*CIP, ciprofloxacin; NAL, nalidixic acid.
†Data collected from statistics reports, Finland, based on the no. of Finnish travelers to these countries.
‡No. Finnish travelers to Thailand from 2003 to 2007: 21,873; 22,882; 17,661; 21,941; and 38,115, respectively.
§Includes Canary Islands.

Main Article

TOP